← Front page
The Work

The Work

Reporting on the people, methods, and practical questions shaping mental health work.

Real people.
Real questions.
A clearer view.

THE WORK · RESEARCH Draulio B. Araújo · Professor, Brain Institute, Federal University of Rio Grande do Norte · Director, Centro Avançado de Medicina Psicodélica

From ayahuasca to DMT: Draulio Araújo on why a negative trial would still advance the science

Draulio B. Araújo's research moved from studying consciousness during the acute ayahuasca experience to a randomized trial in treatment-resistant depression, and now to an ongoing Phase 2b DMT study built specifically to find out whether that early signal survives blinding, an active comparator, and outcomes that go beyond a symptom scale.

By Editorial Desk · September 24, 2026 · 13 min read
Read the work →
What The Work is

A closer look at the people behind the work.

Reported pieces on the people working on the questions reshaping mental health.

The Work looks at the people working directly on questions that can be obscured by trial readouts, regulatory decisions, and company announcements. Each piece begins with a practitioner, researcher, operator, or other contributor and examines the problem they are trying to solve, what their work reveals, and where the uncertainties remain.

These are reported pieces, not profiles or endorsements. Behavioral Wire independently frames, verifies, and contextualizes the work.

Latest from The Work

THE WORK · RESEARCH

Amanda Wilde wants postpartum psilocybin studied directly. The strongest counterevidence comes from mice.

A Harvard-trained researcher wants the first controlled human study of psilocybin in postpartum mothers, arguing that widespread unsupervised use has already outpaced the evidence. A 2025 mouse study is the most direct data yet that the postpartum body responds differently to the drug, and it settles the question for neither side.

By Editorial Desk · September 15, 2026 · 11 min read
→